Coexistence of t(5;17)/NPM1-RARA and t(9;22)/BCR-ABL1 in chronic myeloid leukemia at initial diagnosis

Ann Hematol. 2019 May;98(5):1319-1321. doi: 10.1007/s00277-018-3537-9. Epub 2018 Oct 30.

Authors

Yan Li¹, Haigang Shao², Bin Fu³

Affiliations

¹ Department of Hematology, Xiangya Hospital Central South University, 87 Xiangya Road, Changsha, 410008, People's Republic of China.
² Department of Hematology, The Third Xiangya Hospital of the Central South University, 138 Tongzipo Road, Changsha, 410013, People's Republic of China.
³ Department of Hematology, Xiangya Hospital Central South University, 87 Xiangya Road, Changsha, 410008, People's Republic of China. [email protected].

PMID: 30377763
DOI: 10.1007/s00277-018-3537-9

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Chromosomes, Human / genetics*
Fusion Proteins, bcr-abl / genetics*
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / diagnosis
Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / genetics
Male
Middle Aged
Nuclear Proteins / genetics*
Nucleophosmin
Retinoic Acid Receptor alpha / genetics*
Translocation, Genetic*

Substances

BCR-ABL1 fusion protein, human
NPM1 protein, human
Nuclear Proteins
RARA protein, human
Retinoic Acid Receptor alpha
Nucleophosmin
Fusion Proteins, bcr-abl

Grants and funding

2010TD2022/Hunan Provincial Science and Technology Department (CN)